Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: Implications of HLA and ABO genotypes

Cell Transplantation

Volumn 19, Issue 11, 2010, Pages 1383-1395

  Lee, Jeoung Eun ^a   Kang, Myung Seo ^a   Park, Myoung Hee ^b   Shim, Sung Han ^a   Yoon, Tae Ki ^a   Chung, Hyung Min ^a,c   Lee, Dong Ryul ^a  

^a CHA University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c CHA Stem Cell Institute   (South Korea)

Author keywords

ABO genotype; Cell therapy; Donated cord blood; HLA genotype; Human embryonic stem cells (hESCs)

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DNA FINGERPRINTING; EMBRYO; EMBRYONIC STEM CELL; GENOTYPE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ABO BLOOD-GROUP SYSTEM; ALLELES; BLOOD GROUPING AND CROSSMATCHING; CELL LINE; EMBRYONIC STEM CELLS; FETAL BLOOD; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; TISSUE DONORS;

EID: 78651469084     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X513991     Document Type: Article

References (73)

1. Amit, M.; Carpenter, M. K.; Inokuma, M. S.; Chiu, C. P.; Harris, C. P.; Waknitz, M. A.; Itskovitz-Eldor, J.; Thomson, J. A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227(2):271-278; 2000.
2. Amit, M.; Margulets, V.; Segev, H.; Shariki, K.; Laevsky, I.; Coleman, R.; Itskovitz-Eldor, J. Human feeder layers for human embryonic stem cells. Biol. Reprod. 68(6):2150-2156; 2003.
3. Beattie, G. M.; Lopez, A. D.; Bucay, N.; Hinton, A.; Firpo, M. T.; King, C. C.; Hayek, A. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23(4):489-495; 2005.
4. Bodnar, M. S.; Meneses, J. J.; Rodriguez, R. T.; Firpo, M. T. Propagation and maintenance of undifferentiated human embryonic stem cells. Stem Cells Dev. 13(3):243-253; 2004.
5. Boyd, A. S.; Higashi, Y.; Wood, K. J. Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv. Drug Deliv. Rev. 57(13):1944-1969; 2005.
6. Bradley, J. A.; Bolton, E. M.; Pedersen, R. A. Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2(11):859-871; 2002.
7. Buzzeo, M. P.; Yang, J.; Casella, G.; Reddy, V. A preliminary gene expression profile of acute graft-versus-host disease. Cell Transplant. 17(5):489-494; 2008.
8. Cabrera, C. M.; Nieto, A.; Cortes, J. L.; Montes, R. M.; Catalina, P.; Cobo, F.; Barroso-Del-Jesus, A.; Concha, A. The low rate of HLA class I molecules on the human embryonic stem cell line HS293 is associated with the APM components' expression level. Cell Biol. Int. 31(9):1072-1078; 2007.
9. Chen, Y. T.; Dejosez, M.; Zwaka, T. P.; Behringer, R. R. H1 and H9 human embryonic stem cell lines are heterozygous for the ABO locus. Stem Cells Dev. 17(5):853-855; 2008.
10. Crook, J. M.; Peura, T. T.; Kravets, L.; Bosman, A. G.; Buzzard, J. J.; Horne, R.; Hentze, H.; Dunn, N. R.; Zweigerdt, R.; Chua, F.; Upshall, A.; Colman, A. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 1(5):490-494; 2007.
11. Drukker, M. Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines. Semin. Immunol. 20(2):123-129; 2008.
12. Drukker, M.; Benvenisty, N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22(3):136-141; 2004.
13. Drukker, M.; Katchman, H.; Katz, G.; Even-Tov Friedman, S.; Shezen, E.; Hornstein, E.; Mandelboim, O.; Reisner, Y.; Benvenisty, N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24(2):221-229; 2006.
14. Drukker, M.; Katz, G.; Urbach, A.; Schuldiner, M.; Markel, G.; Itskovitz-Eldor, J.; Reubinoff, B.; Mandelboim, O.; Benvenisty, N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99(15):9864-9869; 2002.
15. Eapen, M.; Rubinstein, P.; Zhang, M. J.; Stevens, C.; Kurtzberg, J.; Scaradavou, A.; Loberiza, F. R.; Champlin, R. E.; Klein, J. P.; Horowitz, M. M.; Wagner, J. E. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study. Lancet 369(9577):1947-1954; 2007.
16. Fernandes, A. M.; Meletti, T.; Guimaraes, R.; Stelling, M. P.; Marinho, P. A.; Valladao, A. S.; Rehen, S. K. Worldwide survey of published procedures to culture human embryonic stem cells. Cell Transplant. 19(5):509-523; 2010.
17. Genbacev, O.; Krtolica, A.; Zdravkovic, T.; Brunette, E.; Powell, S.; Nath, A.; Caceres, E.; McMaster, M.; McDonagh, S.; Li, Y.; Mandalam, R.; Lebkowski, J.; Fisher, S. J. Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil. Steril. 83(5):1517-1529; 2005.
18. Guhr, A.; Kurtz, A.; Friedgen, K.; Loser, P. Current state of human embryonic stem cell research: An overview of cell lines and their use in experimental work. Stem Cells 24(10):2187-2191; 2006.
19. Helming, A. M.; Brand, A.; Wolterbeek, R.; van Tol, M. J.; Egeler, R. M.; Ball, L. M. ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr. Blood Cancer 49(3):313-317; 2007.
20. Hoffman, L. M.; Carpenter, M. K. Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23(6):699-708; 2005.
21. Holdsworth, R.; Hurley, C. K.; Marsh, S. G.; Lau, M.; Noreen, H. J.; Kempenich, J. H.; Setterholm, M.; Maiers, M. The HLA dictionary 2008: A summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens 73(2):95-170; 2009.
22. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D. A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26(11):1269-1275; 2008.
23. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458(7239):771-775; 2009.
24. Kamani, N.; Spellman, S.; Hurley, C. K.; Barker, J. N.; Smith, F. O.; Oudshoorn, M.; Bray, R.; Smith, A.; Williams, T. M.; Logan, B.; Eapen, M.; Anasetti, C.; Setterholm, M.; Confer, D. L. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol. Blood Marrow Transplant. 14(1):1-6; 2008.
25. Kastenberg, Z. J.; Odorico, J. S. Alternative sources of pluripotency: Science, ethics, and stem cells. Transplant. Rev. 22(3):215-222; 2008.
26. Klumpp, T. R.; Herman, J. H.; Ulicny, J.; Emmons, R. V.; Martin, M. E.; Mangan, K. F. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 38(9):615-620; 2006.
27. Koivisto, H.; Hyvarinen, M.; Stromberg, A. M.; Inzunza, J.; Matilainen, E.; Mikkola, M.; Hovatta, O.; Teerijoki, H. Cultures of human embryonic stem cells: Serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reprod. Biomed. Online 9(3):330-337; 2004.
28. Laughlin, M. J.; Eapen, M.; Rubinstein, P.; Wagner, J. E.; Zhang, M. J.; Champlin, R. E.; Stevens, C.; Barker, J. N.; Gale, R. P.; Lazarus, H. M.; Marks, D. I.; van Rood, J. J.; Scaradavou, A.; Horowitz, M. M. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351(22):2265-2275; 2004.
29. Lee, J. B.; Lee, J. E.; Park, J. H.; Kim, S. J.; Kim, M. K.; Roh, S. I.; Yoon, H. S. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol. Reprod. 72(1):42-49; 2005.
30. Lee, J. Y.; Lee, J. E.; Kim, D. K.; Yoon, T. K.; Chung, H. M.; Lee, D. R. High concentration of synthetic serum, stepwise equilibration and slow cooling as an efficient technique for large-scale cryopreservation of human embryonic stem cells. Fertil. Steril. 93(3):976-985; 2010.
31. Lee, S. J.; Klein, J.; Haagenson, M.; Baxter-Lowe, L. A.; Confer, D. L.; Eapen, M.; Fernandez-Vina, M.; Flomenberg, N.; Horowitz, M.; Hurley, C. K.; Noreen, H.; Oudshoorn, M.; Petersdorf, E.; Setterholm, M.; Spellman, S.; Weisdorf, D.; Williams, T. M.; Anasetti, C. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110(13):4576-4583; 2007.
32. Lehec, S. C.; Hughes, R. D.; Mitry, R. R.; Graver, M. A.; Verma, A.; Wade, J. J.; Dhawan, A. Experience of microbiological screening of human hepatocytes for clinical transplantation. Cell Transplant. 18(8):941-947; 2009.
33. Lei, T.; Jacob, S.; Ajil-Zaraa, I.; Dubuisson, J. B.; Irion, O.; Jaconi, M.; Feki, A. Xeno-free derivation and culture of human embryonic stem cells: Current status, problems and challenges. Cell Res. 17(8):682-688; 2007.
34. Li, L.; Baroja, M. L.; Majumdar, A.; Chadwick, K.; Rouleau, A.; Gallacher, L.; Ferber, I.; Lebkowski, J.; Martin, T.; Madrenas, J.; Bhatia, M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22(4):448-456; 2004.
35. Li, Y.; Powell, S.; Brunette, E.; Lebkowski, J.; Mandalam, R. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng. 91(6):688-698; 2005.
36. Lin, G.; Ouyang, Q.; Zhou, X.; Gu, Y.; Yuan, D.; Li, W.; Liu, G.; Liu, T.; Lu, G. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res. 17(12):999-1007; 2007.
37. Ludwig, T. E.; Levenstein, M. E.; Jones, J. M.; Berggren, W. T.; Mitchen, E. R.; Frane, J. L.; Crandall, L. J.; Daigh, C. A.; Conard, K. R.; Piekarczyk, M. S.; Llanas, R. A.; Thomson, J. A. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24(2):185-187; 2006.
38. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1(1):55-70; 2007.
39. Molne, J.; Bjorquist, P.; Andersson, K.; Diswall, M.; Jeppsson, A.; Strokan, V.; Rydberg, L.; Breimer, M. E. Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells. Transplantation 86(10):1407-1413; 2008.
40. Mountford, J. C. Human embryonic stem cells: Origins, characteristics and potential for regenerative therapy. Transfus. Med. 18(1):1-12; 2008.
41. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.; Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1):101-106; 2008.
42. Nakajima, F.; Tokunaga, K.; Nakatsuji, N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 25(4):983-985; 2007.
43. Navarro-Alvarez, N.; Soto-Gutierrez, A.; Yuasa, T.; Yamatsuji, T.; Shirakawa, Y.; Nagasaka, T.; Sun, S. D.; Javed, M. S.; Tanaka, N.; Kobayashi, N. Long-term culture of Japanese human embryonic stem cells in feeder-free conditions. Cell Transplant. 17(1-2):27-33; 2008.
44. Oh, S. K.; Choo, A. B. Human embryonic stem cells: Technological challenges towards therapy. Clin. Exp. Pharmacol. Physiol. 33(5-6):489-495; 2006.
45. Oishi, K.; Noguchi, H.; Yukawa, H.; Hayashi, S. Differential ability of somatic stem cells. Cell Transplant. 18(5-6):581-589; 2009.
46. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germ-line-competent induced pluripotent stem cells. Nature 448(7151):313-317; 2007.
47. Park, I. H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A.; Lensch, M. W.; Cowan, C.; Hochedlinger, K.; Daley, G. Q. Disease-specific induced pluripotent stem cells. Cell 134(5):877-886; 2008.
48. Park, I. H.; Zhao, R.; West, J. A.; Yabuuchi, A.; Huo, H.; Ince, T. A.; Lerou, P. H.; Lensch, M. W.; Daley, G. Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141-146; 2008.
49. Petersdorf, E. W. Optimal HLA matching in hematopoietic cell transplantation. Curr. Opin. Immunol. 20(5):588-593; 2008.
50. Petersdorf, E. W.; Mickelson, E. M.; Anasetti, C.; Martin, P. J.; Woolfrey, A. E.; Hansen, J. A. Effect of HLA mismatches on the outcome of hematopoietic transplants. Curr. Opin. Immunol. 11(5):521-526; 1999.
51. Priddle, H.; Jones, D. R.; Burridge, P. W.; Patient, R. Hematopoiesis from human embryonic stem cells: Overcoming the immune barrier in stem cell therapies. Stem Cells 24(4):815-824; 2006.
52. Reubinoff, B. E.; Pera, M. F.; Fong, C. Y.; Trounson, A.; Bongso, A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat. Biotechnol. 18(4):399-404; 2000.
53. Revazova, E. S.; Turovets, N. A.; Kochetkova, O. D.; Agapova, L. S.; Sebastian, J. L.; Pryzhkova, M. V.; Smolnikova, V. I.; Kuzmichev, L. N.; Janus, J. D. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 10(1):11-24; 2008.
54. Richards, M.; Fong, C. Y.; Chan, W. K.; Wong, P. C.; Bongso, A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20(9):933-936; 2002.
55. Rocha, V.; Labopin, M.; Sanz, G.; Arcese, W.; Schwerdtfeger, R.; Bosi, A.; Jacobsen, N.; Ruutu, T.; de Lima, M.; Finke, J.; Frassoni, F.; Gluckman, E. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351(22):2276-2285; 2004.
56. Saric, T.; Frenzel, L. P.; Hescheler, J. Immunological barriers to embryonic stem cell-derived therapies. Cells Tissues Organs 188(1-2):78-90; 2008.
57. Shaw, B. E.; Gooley, T. A.; Malkki, M.; Madrigal, J. A.; Begovich, A. B.; Horowitz, M. M.; Gratwohl, A.; Ringden, O.; Marsh, S. G.; Petersdorf, E. W. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 110(13):4560-4566; 2007.
58. Skottman, H.; Dilber, M. S.; Hovatta, O. The derivation of clinical-grade human embryonic stem cell lines. FEBS Lett. 580(12):2875-2878; 2006.
59. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322(5903):945-949; 2008.
60. Strom, S.; Inzunza, J.; Grinnemo, K. H.; Holmberg, K.; Matilainen, E.; Stromberg, A. M.; Blennow, E.; Hovatta, O. Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. Hum. Reprod. 22(12):3051-3058; 2007.
61. Stussi, G.; Halter, J.; Schanz, U.; Seebach, J. D. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfus. Apher. Sci. 35(1):59-69; 2006.
62. Swijnenburg, R. J.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A. J.; Davis, M. M.; Robbins, R. C.; Wu, J. C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA 105(35):12991-12996; 2008.
63. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676; 2006.
64. Taylor, C. J.; Bolton, E. M.; Pocock, S.; Sharples, L. D.; Pedersen, R. A.; Bradley, J. A. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 366(9502):2019-2025; 2005.
65. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147; 1998.
66. Unger, C.; Skottman, H.; Blomberg, P.; Dilber, M. S.; Hovatta, O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17(R1):R48-53; 2008.
67. Vallier, L.; Alexander, M.; Pedersen, R. A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118(Pt. 19):4495-4509; 2005.
68. Wang, G.; Zhang, H.; Zhao, Y.; Li, J.; Cai, J.; Wang, P.; Meng, S.; Feng, J.; Miao, C.; Ding, M.; Li, D.; Deng, H. Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem. Biophys. Res. Commun. 330(3):934-942; 2005.
69. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B. E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151):318-324; 2007.
70. Xiao, L.; Yuan, X.; Sharkis, S. J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24(6):1476-1486; 2006.
71. Xu, C.; Inokuma, M. S.; Denham, J.; Golds, K.; Kundu, P.; Gold, J. D.; Carpenter, M. K. Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19(10):971-974; 2001.
72. Xu, R. H.; Peck, R. M.; Li, D. S.; Feng, X.; Ludwig, T.; Thomson, J. A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2(3):185-190; 2005.
73. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I. I.; Thomson, J. A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797-801; 2009.